20 results on '"Lohmann, Kristina"'
Search Results
2. Correction to: Real-World Clinical Practice Use of 8-Week Glecaprevir/Pibrentasvir in Treatment-Naïve Patients with Compensated Cirrhosis
3. 52654 Reaching high treatment goals is linked with a high quality of life in psoriasis patients; 1-year data from the German VALUE study
4. 51362 Overall effectiveness of Risankizumab in special areas and the impact on quality of life; 1-year real world data from the German cohort of the VALUE study
5. Real-World Safety, Effectiveness, and Patient-Reported Outcomes in Patients with Chronic Hepatitis C Virus Infection Treated with Glecaprevir/Pibrentasvir: Updated Data from the German Hepatitis C-Registry (DHC-R)
6. Development and evaluation of an algorithm to facilitate drug prescription for inpatients with feeding tubes
7. The changing characteristics of patients infected with chronic hepatitis C virus from 2014 to 2019: Real‐world data from the German Hepatitis C‐Registry (DHC‐R)
8. Knowledge and training needs of nurses and physicians on unsuitable drugs for patients with dysphagia or feeding tubes
9. Opportunities to Reduce Medication Regimen Complexity: A Retrospective Analysis of Patients Discharged from a University Hospital in Germany
10. Hepatitis C virus: Current steps toward elimination in Germany and barriers to reaching the 2030 goal
11. Glecaprevir/pibrentasvir for 8 weeks in patients with compensated cirrhosis: Safety and effectiveness data from the German Hepatitis C‐Registry
12. Glecaprevir/pibrentasvir is safe and effective in hepatitis C patients with cirrhosis: Real‐world data from the German Hepatitis C‐Registry
13. Safeguarding the process of drug administration with an emphasis on electronic support tools
14. Development of a standardized knowledge base to generate individualized medication plans automatically with drug administration recommendations
15. GS-07-Real-world safety, effectiveness, and patient-reported outcomes in patients with chronic hepatitis C virus infection treated with glecaprevir/pibrentasvir: Data from the German Hepatitis C-Registry
16. Real-world effectiveness and safety of glecaprevir/pibrentasvir for the treatment of chronic hepatitis C infection: data from the German Hepatitis C-Registry
17. 1981. Real-World Data on Safety and Effectiveness of Glecaprevir/Pibrentasvir for the Treatment of Patients With Chronic Hepatitis C Virus Infection on Opioid Substitution Therapy: Latest Results from the German Hepatitis C-Registry
18. Development of a standardized knowledge base to generate individualized medication plans automatically with drug administration recommendations
19. Inappropriate crushing information on ward lists: cytotoxic drugs, capsules, and modified release formulations are gravely neglected
20. Opportunities to Reduce Medication Regimen Complexity
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.